CaPre (TM)
PRT-API-NKPL66-CT-PII
Phase 2 small_molecule completed
Quick answer
CaPre (TM) for Hypertriglyceridemia is a Phase 2 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Grace Therapeutics
- Indication
- Hypertriglyceridemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed